Romano Kelly A - Insider Non-Derivative Transactions at Athira Pharma, Inc. (ATHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 24, 2024, Romano Kelly A's relationship to Athira Pharma, Inc. (ATHA) is Director, and currently has 80,715 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATHA insiders.
Data Source: SEC.
Romano Kelly A - Insider Non-Derivative Transactions of ATHA Common Stock
Romano Kelly A - Insider Non-Derivative Transactions at ATHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 25, 2024 | P -- (Common Stock) | 27400 | 2.42 | 80715 |
| Jun 22, 2024 | P -- (Common Stock) | 15000 | 2.26 | 53315 |